<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
JULY 20, 2000
-----------------------------------------------
Date of Report (Date of earliest event reported)
AMERICAN BIOMED, INC.
(Exact Name of Registrant as Specified in Charter)
DELAWARE 0-19606 76-0136574
----------------------------- ----------------- ------------------
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
14800 QUORUM DRIVE, SUITE 2000
DALLAS, TEXAS 75240
(Address of Principal Executive Offices, Including Zip Code)
(972) 308-8575
-------------------------------
(Registrant's telephone number,
including area code)
<PAGE> 2
AMERICAN BIOMED, INC.
FORM 8-K
ITEM 3. BANKRUPTCY OR RECEIVERSHIP.
On July 20, 2000, American BioMed, Inc. (the "Company") filed a
voluntary petition for bankruptcy under Chapter 7 of the U.S. Bankruptcy Code in
the Northern District Court of Texas, Dallas Division, Case No. 00-34624 SAF.
John Litzler was appointed as Trustee. The press release of the Company related
to the bankruptcy filing is filed as Exhibit 99.1 to this Current Report on Form
8-K, and the contents of such exhibit is incorporated herein by reference.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) EXHIBITS.
The exhibit filed as a part of this report is listed on the Index to
Exhibits on page 2 of this report, which Index is incorporated in this Item 7 by
reference.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Date: July 31, 2000 AMERICAN BIOMED, INC.
By: /s/ JUSTINE B. CORDAY
------------------------------------
Justine B. Corday
Chairman and Chief Executive Officer
- 1 -
<PAGE> 3
INDEX TO EXHIBITS
The following exhibits to this report are incorporated herein by
reference:
<TABLE>
<CAPTION>
EXHIBIT
NUMBER DESCRIPTION
------- -----------
<S> <C>
99.01 Press Release issued by American BioMed, Inc. on
July 20, 2000.
</TABLE>
- 2 -
